Cargando…
Potential benefits of ginseng against COVID-19 by targeting inflammasomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogenic virus that causes coronavirus disease 2019 (COVID-19), with major symptoms including hyper-inflammation and cytokine storm, which consequently impairs the respiratory system and multiple organs, or even cause death. SARS-...
Autor principal: | Yi, Young-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979607/ https://www.ncbi.nlm.nih.gov/pubmed/35399195 http://dx.doi.org/10.1016/j.jgr.2022.03.008 |
Ejemplares similares
-
Panax ginseng as a potential therapeutic for neurological disorders associated with COVID-19; Toward targeting inflammasome
por: Shin, Seo Won, et al.
Publicado: (2023) -
Regulatory roles of ginseng on inflammatory caspases, executioners of inflammasome activation
por: Yun, Miyong, et al.
Publicado: (2020) -
Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic
por: Jung, Eui-Man, et al.
Publicado: (2022) -
Potential Oral Health Benefits of Ginseng and Its Extracts
por: Peng, Yuqing, et al.
Publicado: (2023) -
Korean Red Ginseng Saponins Play an Anti-Inflammatory Role by Targeting Caspase-11 Non-Canonical Inflammasome in Macrophages
por: Cho, Hui-Jin, et al.
Publicado: (2023)